A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients
MAUD was rarely administered during hospitalization, representing a critical missed opportunity for intervention. While effect estimates favored treated patients, limited sample size precluded definitive conclusions. Efforts to improve implementation of AUD pharmacotherapy in inpatient settings are warranted.
Authors
- Jérémie Richard (ORCID: https://orcid.org/0000-0001-9893-1353)
- Steven Tate (ORCID: https://orcid.org/0000-0001-9544-594X)
- Anna Lembke (ORCID: https://orcid.org/0000-0002-1352-487X)
- Paola Lavín (ORCID: https://orcid.org/0000-0003-0733-9261)
- Kyle T. Greenway (ORCID: https://orcid.org/0000-0002-7829-493X)
- Michka Nazon
- Nicolas Garel
- Didier Jutras-Aswad
- C William Pike
- Paul L’Espérance
Institutions
- Johns Hopkins University (US)
- VA Palo Alto Health Care System (US)
- Johns Hopkins Medicine (US)
- Jewish General Hospital (CA)
- Behavioral Pharma (United States) (US)
- Centre Hospitalier de l’Université de Montréal (CA)
- McGill University (CA)
- Université de Montréal (CA)
- New York Chiropractic College (US)
- Stanford University (US)
Publication Details
- Journal
- Alcohol and Alcoholism
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1093/alcalc/agag008
- Primary Topic
- Substance Abuse Treatment and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00